Treatment of lysosomal storage disorders: Cell therapy and gene therapy

By Eto Y.   Shen J. -S.   Meng X. -L.   Ohashi T.  

Journal of Inherited Metabolic Disease, Vol. 27, Iss. 3, 2004-01 ,pp. : 411-415

Springer Publishing Company

Access to resources Recommend Favorite

Cellular Therapy of Lysosomal Storage Disorders: Current Status and Future Prospects

By  

Current Pediatric Reviews, Vol. 5, Iss. 3, 2009-08 ,pp. : 147-159

Bentham Science Publishers

Access to resources Recommend Favorite

Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy

By Marshall John   McEachern Kerry   Chuang Wei-Lien   Hutto Elizabeth   Siegel Craig   Shayman James   Grabowski Greg   Scheule Ronald   Copeland Diane   Cheng Seng  

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 3, 2010-06 ,pp. : 281-289

Springer Publishing Company

Access to resources Recommend Favorite

Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice

By te Vruchte Danielle   Jeans Aruna   Platt Frances   Sillence Daniel  

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 3, 2010-06 ,pp. : 261-270

Springer Publishing Company

Access to resources Recommend Favorite

Pathophysiology of neuropathic lysosomal storage disorders

By Bellettato Cinzia   Scarpa Maurizio  

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 4, 2010-08 ,pp. : 347-362

Springer Publishing Company

Access to resources Recommend Favorite